|
2018 Journal Article Whole-exome sequencing of acquired nevi identifies mechanisms for development and maintenance of benign neoplasmsStark, Mitchell S., Tan, Jean-Marie, Tom, Lisa, Jagirdar, Kasturee, Lambie, Duncan, Schaider, Helmut, Soyer, H. Peter and Sturm, Richard A. (2018). Whole-exome sequencing of acquired nevi identifies mechanisms for development and maintenance of benign neoplasms. Journal of Investigative Dermatology, 138 (7), 1636-1644. doi: 10.1016/j.jid.2018.02.012 |
|
2018 Journal Article The BRAF and NRAS mutation prevalence in dermoscopic subtypes of acquired naevi reveals constitutive MAPK pathway activationTan, J. M., Tom, L. N., Jagirdar, K., Lambie, D., Schaider, H., Sturm, R. A., Soyer, H. P. and Stark, M. S. (2018). The BRAF and NRAS mutation prevalence in dermoscopic subtypes of acquired naevi reveals constitutive MAPK pathway activation. British Journal of Dermatology, 178 (1), 191-197. doi: 10.1111/bjd.15809 |
|
2018 Conference Publication Distinct epigenetic remodelling defines early stress-induced drug tolerance in melanomaEmran, A., Marzese, D. M., Menon, D. R., Stark, M., Torrano, J., Hammerlindl, H., Zhang, G., Brafford, P., Hammerlindl, S., Gupta, D., Mills, G. B., Lu, Y., Flaherty, K., Sturm, R., Hoon, D. S. B., Gabrielli, B., Herlyn, M. and Schaider, H. (2018). Distinct epigenetic remodelling defines early stress-induced drug tolerance in melanoma. Australasian College of Dermatologists, 51st Annual Scientific Meeting, Gold Coast, QLD, Australia , 19–22 May 2018. Richmond, VIC, Australia: Wiley-Blackwell Publishing. doi: 10.1111/ajd.16_12815 |
|
2018 Conference Publication Magnolol induces cell death through PI3K/Akt mediated epigenetic modifications boosting targeted inhibition in BRAF and NRAS mutant melanomaEmran, A., Chowdhury, B. R., Hammerlindl, H., Ahmed, F., Haass, N. K., Schuehly, W. and Schaider, H. (2018). Magnolol induces cell death through PI3K/Akt mediated epigenetic modifications boosting targeted inhibition in BRAF and NRAS mutant melanoma. Australasian College of Dermatologists, 51st Annual Scientific Meeting, Gold Coast, QLD, Australia, 19-22 May 2018. Hoboken, NJ, United States: Wiley. |
|
2018 Conference Publication Escape form adaptive drug tolerance through OGT and TET1 mediated H3K4me3 remodeling in MAPKi resistant melanomaMenon, Dinoop Ravindran, Hammerlindl, Heinz, Al Emran, Abdullah, Torrano, Joachim, Hammerlindl, Sabrina, Zhang, Gao, Somasundaram, Rajasekharan, Sturm, Richard A., Haass, Nikolas K., Flaherty, Keith, Herlyn, Meenhard and Schaider, Helmut (2018). Escape form adaptive drug tolerance through OGT and TET1 mediated H3K4me3 remodeling in MAPKi resistant melanoma. Annual Meeting of the American Association for Cancer Research (AACR), Chicago, IL United States, 14-18 April 2018. Philadelphia, PA United States: American Association of Cancer Research. doi: 10.1158/1538-7445.AM2018-5833 |
|
2018 Conference Publication Whole-exome sequencing of acquired nevi identifies novel mechanisms for development and maintenance of benign neoplasmsStark, Mitchell S., Tan, Jean-Marie, Tom, Lisa, Jagirdar, Kasturee, Lambie, Duncan, Schaider, Helmut, Soyer, H. Peter and Sturm, Richard A. (2018). Whole-exome sequencing of acquired nevi identifies novel mechanisms for development and maintenance of benign neoplasms. Annual Meeting of the American Association for Cancer Research (AACR), Chicago, Illinois, 14-18 April 2018. Philadelphia, PA, United States: American Association for Cancer Research. doi: 10.1158/1538-7445.AM2018-5376 |
|
2018 Conference Publication Fighting melanoma - human lactoferricin derived peptides kill cancer cells by inducing severe stress and apoptosisRiedl, Sabrina, Rinner, Beate, Schaider, Helmut, Liegl-Atzwanger, Bernadette, Wodlej, Christina, Grissenberger, Sarah, Preishuber-Pfluegl, Julia, Lohner, Karl and Zweytick, Dagmar (2018). Fighting melanoma - human lactoferricin derived peptides kill cancer cells by inducing severe stress and apoptosis. 35th European Peptide Symposium, Dublin, Ireland, 26th-31st August, 2018 . Oxford, United Kingdom: John Wiley & Sons . |
|
2018 Conference Publication Escape form adaptive drug tolerance through OGT and TET1 mediated H3K4me3 remodeling in MAPKi-resistant melanomaMenon, D. Ravindran, Hammerlindl, H., Emran, A., Torrano, J., Hammerlindl, S., Zhang, G., Krause, L., Somasundaram, R., Sturm, R., Haass, N. K., Flaherty, K., Herlyn, M. and Schaider, H. (2018). Escape form adaptive drug tolerance through OGT and TET1 mediated H3K4me3 remodeling in MAPKi-resistant melanoma. International Investigative Dermatology (IID) Meeting, Orlando, Fl, United States, 16-19 May 2018. London, United Kingdom: Nature Publishing Group. doi: 10.1016/j.jid.2018.03.1252 |
|
2018 Conference Publication The expression of chondroitin sulfate proteoglycan 4 (CSPG4) is decreased in BRAF-mutant induced drug-tolerant melanoma cellsUranowska, K., Kalic, T., Karapandza, K., Ellinger, I., Breiteneder, H., Schaider, H. and Hafner, C. (2018). The expression of chondroitin sulfate proteoglycan 4 (CSPG4) is decreased in BRAF-mutant induced drug-tolerant melanoma cells. 45th Annual Meeting of the Arbeitsgemeinscha-Dermatologische-Forschung (ADF), Zurich Switzerland, Mar 07-10, 2018. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. |
|
2018 Conference Publication Distinct expression profiles of chemokine- and nuclear orphan receptors in the development and early progression of follicular lymphomaSchukoff, T., Winkler, S., Unterluggauer, J. J., Fechter, K., Greinix, H., Beham-Schmid, C., Schaider, H., Deutsch, A., Prochazka, K. and Neumeister, P. (2018). Distinct expression profiles of chemokine- and nuclear orphan receptors in the development and early progression of follicular lymphoma. Unknown, Unknown, Unknown. Basel, Switzerland: S. Karger AG. |
|
2017 Journal Article Distinct histone modifications denote early stress-induced drug tolerance in cancerEmran, Abdullah Al, Marzese, Diego M., Menon, Dinoop Ravindran, Stark, Mitchell S., Torrano, Joachim, Hammerlindl, Heinz, Zhang, Gao, Brafford, Patricia, Salomon, Matthew P., Nelson, Nellie, Hammerlindl, Sabrina, Gupta, Deepesh, Mills, Gordon B., Lu, Yiling, Sturm, Richard A., Flaherty, Keith, Hoon, Dave S. B., Gabrielli, Brian, Herlyn, Meenhard and Schaider, Helmut (2017). Distinct histone modifications denote early stress-induced drug tolerance in cancer. Oncotarget, 9 (9), 8206-8222. doi: 10.18632/oncotarget.23654 |
|
2017 Journal Article Co-culture of human fibroblasts and Borrelia burgdorferi enhances collagen and growth factor mRNAAberer, Elisabeth, Surtov-Pudar, Milana, Wilfinger, Daniel, Deutsch, Alexander, Leitinger, Gerd and Schaider, Helmut (2017). Co-culture of human fibroblasts and Borrelia burgdorferi enhances collagen and growth factor mRNA. Archives of Dermatological Research, 310 (2), 117-126. doi: 10.1007/s00403-017-1797-1 |
|
2017 Journal Article Tumor cell-intrinsic phenotypic plasticity facilitates adaptive cellular reprogramming driving acquired drug resistanceHammerlindl, Heinz and Schaider, Helmut (2017). Tumor cell-intrinsic phenotypic plasticity facilitates adaptive cellular reprogramming driving acquired drug resistance. Journal of Cell Communication and Signaling, 12 (1), 133-141. doi: 10.1007/s12079-017-0435-1 |
|
2017 Journal Article The evolving universe of BRAF mutations in melanomaSchaider, H and Sturm, R A (2017). The evolving universe of BRAF mutations in melanoma. The British Journal of Dermatology, 177 (4), 893-893. doi: 10.1111/bjd.15829 |
|
2017 Journal Article Classifying dermoscopic patterns of naevi in a case-control study of melanomaMcWhirter, Seamus R, Duffy, David L, Lee, Katie J, Wimberley, Glen, McClenahan, Philip, Ling, Natalie, Ardigo, Marco, Schaider, Helmut, Soyer, H Peter and Sturm, Richard A (2017). Classifying dermoscopic patterns of naevi in a case-control study of melanoma. PloS One, 12 (10) e0186647, 1-10. doi: 10.1371/journal.pone.0186647 |
|
2017 Journal Article Protocol for the TIDAL Melanoma Study: topical imiquimod or diphenylcyclopropenone for the management of cutaneous in-transit melanoma metastases-a phase II, single centre, randomised, pilot studyRead, Tavis, Webber, Scott, Thomas, Janine, Wagels, Michael, Schaider, Helmut, Soyer, H. Peter and Smithers, B. Mark (2017). Protocol for the TIDAL Melanoma Study: topical imiquimod or diphenylcyclopropenone for the management of cutaneous in-transit melanoma metastases-a phase II, single centre, randomised, pilot study. BMJ Open, 7 (10) e016816, 1-8. doi: 10.1136/bmjopen-2017-016816 |
|
2017 Journal Article A path through the reticulate pigmentation disorder jungleSchaider, H. and Sturm, R. A. (2017). A path through the reticulate pigmentation disorder jungle. British Journal of Dermatology, 177 (4), 893-893. doi: 10.1111/bjd.15805 |
|
2017 Journal Article Tumor-associated B-cells induce tumor heterogeneity and therapy resistanceSomasundaram, Rajasekharan, Zhang, Gao, Fukunaga-Kalabis, Mizuho, Perego, Michela, Krepler, Clemens, Xu, Xiaowei, Wagner, Christine, Hristova, Denitsa, Zhang, Jie, Tian, Tian, Wei, Zhi, Liu, Qin, Garg, Kanika, Griss, Johannes, Hards, Rufus, Maurer, Margarita, Hafner, Christine, Mayerhofer, Marius, Karanikas, Georgios, Jalili, Ahmad, Bauer-Pohl, Verena, Weihsengruber, Felix, Rappersberger, Klemens, Koller, Josef, Lang, Roland, Hudgens, Courtney, Chen, Guo, Tetzlaff, Michael, Wu, Lawrence ... Wagner, Stephan N. (2017). Tumor-associated B-cells induce tumor heterogeneity and therapy resistance. Nature Communications, 8 (1) 607, 607. doi: 10.1038/s41467-017-00452-4 |
|
2017 Journal Article Diphenylcyclopropenone for the treatment of cutaneous in-transit melanoma metastases - results of a prospective, non-randomized, single-centre studyRead, T., Webber, S., Tan, J., Wagels, M., Schaider, H., Soyer, H. P. and Smithers, B. M. (2017). Diphenylcyclopropenone for the treatment of cutaneous in-transit melanoma metastases - results of a prospective, non-randomized, single-centre study. Journal of the European Academy of Dermatology and Venereology, 31 (12), 2030-2037. doi: 10.1111/jdv.14422 |
|
2017 Journal Article Pregnancy as driver for melanomaRichtig, G., Byrom, L., Kupsa, R., Schaider, H., Hofmann-Wellenhof, R., Wolf, I. H., Soyer, H. P. and Richtig, E. (2017). Pregnancy as driver for melanoma. British Journal of Dermatology, 177 (3), 854-857. doi: 10.1111/bjd.15124 |
